TY - JOUR
T1 - Hospitalization for caffeine abuse is associated with abuse of other pharmaceutical products
AU - McCarthy, Danielle M.
AU - Mycyk, Mark B.
AU - DesLauriers, Carol A.
PY - 2008/9
Y1 - 2008/9
N2 - Study Objective: The aim of this study was to examine the characteristics and outcomes of patients seeking treatment for abuse of supplemental caffeine. Methods: This was a 3-year analysis conducted of all consecutive cases involving caffeine abuse in patients 10 years and older reported to a regional poison center. Excluded were suicide attempts, therapeutic errors, and cases involving only a coffee or tea product. Results: Two hundred fifty-four cases met inclusion criteria. Mean age was 20.5 years, 50% were women. Caffeine was in the form of a nondietary medication in 201 cases, a dietary supplement in 35 cases, and a caffeine-enhanced beverage in 35 cases. Caffeine was abused alone in 174 (68%), with alcohol in 7, illegal drugs in 6 cases, and with other pharmaceutical products in 81 (29%) cases. Thirty-four patients (13% of total) were hospitalized for medical complications from caffeine. Only concomitant abuse of other pharmaceutical products was associated with hospitalization (odds ratio, 3.8; 95% CI, 1.8-8.8; P = .0004). Conclusion: In this cohort, supplemental caffeine was abused primarily by young adults. Concomitant recreational abuse of other pharmaceuticals was associated with hospitalization and warrants further investigation.
AB - Study Objective: The aim of this study was to examine the characteristics and outcomes of patients seeking treatment for abuse of supplemental caffeine. Methods: This was a 3-year analysis conducted of all consecutive cases involving caffeine abuse in patients 10 years and older reported to a regional poison center. Excluded were suicide attempts, therapeutic errors, and cases involving only a coffee or tea product. Results: Two hundred fifty-four cases met inclusion criteria. Mean age was 20.5 years, 50% were women. Caffeine was in the form of a nondietary medication in 201 cases, a dietary supplement in 35 cases, and a caffeine-enhanced beverage in 35 cases. Caffeine was abused alone in 174 (68%), with alcohol in 7, illegal drugs in 6 cases, and with other pharmaceutical products in 81 (29%) cases. Thirty-four patients (13% of total) were hospitalized for medical complications from caffeine. Only concomitant abuse of other pharmaceutical products was associated with hospitalization (odds ratio, 3.8; 95% CI, 1.8-8.8; P = .0004). Conclusion: In this cohort, supplemental caffeine was abused primarily by young adults. Concomitant recreational abuse of other pharmaceuticals was associated with hospitalization and warrants further investigation.
UR - http://www.scopus.com/inward/record.url?scp=50649090017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=50649090017&partnerID=8YFLogxK
U2 - 10.1016/j.ajem.2007.10.018
DO - 10.1016/j.ajem.2007.10.018
M3 - Article
C2 - 18774047
AN - SCOPUS:50649090017
SN - 0735-6757
VL - 26
SP - 799
EP - 802
JO - American Journal of Emergency Medicine
JF - American Journal of Emergency Medicine
IS - 7
ER -